Overview
Modulates growth factor signaling and reduces inflammatory cytokines in hepatocytes.
Proposed mechanism
BPC-157 reduces oxidative stress and inflammation in liver tissue while promoting regeneration.
What the evidence supports
Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Graded Animal
Evidence drawn from in vivo animal models or in vitro systems. Mechanistically informative; translation to humans is unproven.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
BPC-157 in liver injury
· DOI:10.1016/j.ejphar.2013.07.038 · 2013
- [2]
BPC-157 in liver injury (2013)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.